Suneva Medical, Inc is a commercial-stage medical device company with three marketed products focused on the US aesthetics market: Bellafill, a long-lasting, injectable dermal filler, Regenica, a skin rejuvenation product line, and Refissa, a treatment for fine wrinkles.
Suneva is in the attractive aesthetics market, which totaled $13.5 billion in the United States in 2015. Suneva Medical is a commercial-stage medical device company with three marketed products focused on the US aesthetics market. The company's lead product, Bellafill, is a long-lasting, injectable dermal filler. Bellafill is approved for use in two indications: 1) for nasolabial folds (smile lines) and 2) in 2015 became the only filler with FDA approval for the correction of moderate to severe atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years.